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Abstract 
Purpose: To determine the factors associated with severity of hypoglycemia in hospitalized type 2 
diabetes mellitus patients in a tertiary health facility in Malaysia. 
Methods: This retrospective study involved 207 hospitalised T2DM patients with hypoglycaemia 
episodes from January 2008 to December 2012 and was conducted in University Malaya Medical 
Centre, Petaling Jaya, Malaysia. Patients were classified into 2 groups, viz, those who had 
hypoglycaemia on admission and those who had hypoglycaemia during hospital stay. Patients with 
hypoglycemia on admission were those admitted due to hypoglycemia while patients with hypoglycemia 
during hospital stay were those admitted due to other causes but subsequently developed 
hypoglycemia during hospitalization. 
Results: The results for the 207 patients investigated show that most of the patients (72.2 %) were 
asymptomatic during hypoglycemic episodes. The majority of the episodes (57.4 %) experienced by the 
patients were mild hypoglycemia (< 3.9 mmol/L). Old age (p = 0.011) and presence of stroke (p = 0.033) 
were found to be significantly associated with severe hypoglycemia (< 2.2 mmol/L) while concurrent use 
of opioid (p = 0.008) was associated with mild hypoglycemia.   
Conclusion:  The identification of the underlying factors associated with severity of hypoglycemia may 
help in preventing and resolving hypoglycemia in T2DM patients. 
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Diabetes mellitus is an emerging global epidemic 
and is the main illness threatening human health 
in 21st century [1]. In Malaysia, the prevalence of 
diabetes mellitus in 1986 as reported by National 
Morbidity Health Survey (NHMS) is 6.3 % [2]. 
The figure has risen to 8.3 % in 1996 and 14.9 % 
in 2006 [2,3]. In 2012, the figure has achieved 
20.8 % of populations [4]. WHO forecasted that 
2.48 millions of Malaysians will be suffering from 
diabetes mellitus in 2030 [5]. Type 2 diabetes 
mellitus (T2DM) constitutes 85-95 % of diabetes 
mellitus cases in developed countries [6]. 
 
The target clinical outcomes in patients with 
T2DM is good control of fasting blood glucose 
level which is less than 7.2 mmol/L and A1C less 
than 7 % [7]. However, aggressive treatment is 
needed to achieve this target in some patients 
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[8]. This aggressive treatment predisposes 
patients to a higher risk of hypoglycemia that 
become a major hurdle in achieving glycemic 
goal in these patients [9]. Patients treated with 
exogenous insulin as well as insulin 
secretagogues such as sulphonylureas (SUs) 
and meglititnides are at higher risk of getting 
hypoglycemia episodes [9,10]. Besides, the 
present of other co-morbidities such as renal 
failure, liver disease, adrenal deficiency and 
hypopituitarism also predispose patients to 
higher risk of hypoglycemia [11,12]. 
 
Hypoglycemia may affect patients’ daily life in 
which the patients experienced troubling 
symptoms for instance shakiness, anxiety, 
sweating and irritability [13]. In serious condition, 
it may lead to coma, seizure and even may lead 
to fatal [8]. Hypoglycemia often goes undetected 
not only by the patients but also by health care 
providers (HCPs) [8]. In view of serious and life-
threatening effect of hypoglycemia, it is crucial 
for HCPs to understand the clinical factors 
associated with hypoglycemia so that appropriate 
precaution and management can be taken to 
prevent further episodes of hypoglycemia. 
 
This study was aimed to investigate the severity 
of hypoglycemia episodes and clinical factors 
associated with its severity in T2DM patients. 
Hence, data obtained from this study may be 
used to assist the HCPs to enhance and improve 





Sample population, sampling frame and 
sampling size 
 
The study population consisted of hospitalised 
type 2 diabetes mellitus (T2DM) patients with 
hypoglycaemia episodes. Patients were 
classified into 2 groups, those who had 
hypoglycaemia on admission and those who had 
hypoglycaemia during hospital stay. Patients with 
hypoglycemia on admission were those admitted 
due to hypoglycemia while patients with 
hypoglycemia during hospital stay were those 
admitted due to other causes but subsequently 
develop hypoglycemia during hospitalization.  
 
The study employed a convenient sampling 
method from January 2008 to December 2012. 
The minimum sample size of this study was 
calculated using Epi Info Program Version 7.0 
(CDC, Clifton Rd. Atlanta, USA). A minimum of 
108 patients were needed to give a power of β= 
0.8 and confidence level of 95 % for this study. 
 
Study design and procedures 
 
This was a retrospective study conducted in a 
premier teaching hospital in Malaysia with 1200 
beds, which was the University of Malaya 
Medical Centre (UMMC), Malaysia. This study 
was conducted in accordance to Declaration of 
Helsinki and was approved by the Medical Ethics 
Committee (MEC) of UMMC (ref no.956.34). 
MEC of UMMC waived the need for written 
informed consent from the participants. 
 
A total of 1167 potential patients were identified 
via the Hospital Information System (HIS) based 
on International Statistical Classification of 
Diseases and Related Health Problems 10th 
Revision (ICD-10) for T2DM (E11.0-E11.9). In 
the end, 207 patients who fulfilled the inclusion 
criteria were included in this study. Adult T2DM 
aged at least 18 years old, all hospitalized T2DM 
patients with at least one hypoglycemia episode, 
T2DM patients admitted with hypoglycemia 
episode and T2DM patients who were admitted 
to general medical units were included whilst 
T2DM patients without hypoglycemia episode 
and patients with other types of diabetes were 
excluded in the study. 
 
Definition of few terms that was used in this 
study is shown below to ensure the consistency 
of results (Table 1). There were three categories 
of information has been collected which were 
demographic characteristics (such as age, 
gender, ethnicity), clinical characteristics (such 
as duration of diabetes, body mass index, 
smoking habit, alcohol intake, comorbidities that 
require long term drug treatments and concurrent 
medications during hospital stay) and 
hypoglycemia profiles (such as blood glucose 
readings, drugs that cause hypoglycemia, 
symptoms of hypoglycemia and treatment of 
hypoglycemia). The definition of terms used in 




All extracted data were pooled and analyzed 
using the Statistical Package for the Social 
Science (SPSS) software version 20.0 (SPSS 
Inc., Chicago, IL., USA). Continuous data such 
as age was tested for normality using Shapiro-
Wilk Test. A normally distributed result was 
expressed as mean ± standard deviation (SD). 
For categorical data, Chi-square test was used to 
determine the association of patients’ 
characteristics with severity of hypoglycemia 
episodes. When the expected cell counts for > 
20 % was less than 5, Monte-Carlo Exact Test 
was used. On the other hand, independent T-test 
was used to compare mean between groups for 
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continuous data such as mean blood glucose 
level on admission and during hospital stay. The 
statistical significance was assumed at p < 0.05 




Study subject’s disposition 
 
A total of 207 patients were included in the study. 
Male patients have about an equal proportion 
with female patients in this study. The non-
elderly group of patients was slightly more than 
elderly group. The Shapiro-Wilk Test showed 
that the age of patients was normally distributed. 
The mean ± standard deviation (SD) of patients’ 
age was 62.5 ± 12.2 years old with the minimum 
and maximum age were 30 and 97 years old 
respectively. Indian was the most common ethnic 
group in this study. This was followed by Malays, 
Chinese and others ethnics. The demographic 
characteristics of subjects were shown in Table 
1. Majority of the patient population had duration 
of T2DM of less or equal to 10 years. Most 
subjects had their BMI in normal range (5.3 %) 
and 2.9 % were obese. On the other hand, half of 
the patients in this study were non-smoker (50.7 
%). Results also showed that 6.3 % of subjects 
consume alcohol. Hypertension (80.2 %) and 
renal impairment (33.3 %) were the two most 
common comorbidities found whereas the two 
leading concurrent medications were penicillin 
(61.3 %) and statins (54.8 %). 
 
Profile of hypoglycemia episodes 
 
A total of 207 patients were included in this study 
with 248 admissions. From 248 admissions, 
there were 566 hypoglycemia episodes 
experienced by the patients. Majority of patients 
(82.7 %) experienced hypoglycemia episodes 
during hospital stay. 
 
Mean of blood glucose level 
 
There was a trend towards lower mean blood 
glucose level in patients with hypoglycemia 
episodes on admission (2.3 mmol/L) compared 
to those during hospital stay (3.1 mmol/L). The 
trend of mean blood glucose level between these 
2 groups was analyzed using independent 
sample T-test and it was found that patients who 
experienced hypoglycemia episodes on 
admission had significantly lower mean blood 
glucose level (p < 0.0001).  
 
Causes associated with hypoglycemia 
episodes in T2DM patients 
 
The main cause of hypoglycemia in T2DM 
patients is absolute or relative insulin excess due 
to exogenously administered insulin preparations 
or administration of OHAs that stimulate the 
endogenous insulin secretion such as 
sulphonylureas (Table 2). In addition to insulin 
and OHAs, hypoglycemia could be potentiated 
by poor oral intake that could further reduced 
blood glucose level and predisposed patient to 
hypoglycemia as reflected in the Table 3. 
 
Association between causes and severity of 
hypoglycemia 
 
It was found that insulin was associated with mild 
hypoglycemia (Table 3). Besides that, OHAs and 
concurrent loss of appetite was highly associated 
with moderate hypoglycemia. 
 
Severity of hypoglycemia episodes 
 
About half of the episodes (57.4 %) reported 
were mild hypoglycemia. Moderate and severe 
hypoglycemia represents about 30 and 12 % of 
the episodes respectively. 
 
Characteristics Definition Ref 
Demographic 1) Elderly 
    - Older adults above 64 years old 
[14] 
Acute complication 1) Hypoglycemia 
    - Blood glucose less than 3.9 mmol/L  
2) Severity of hypoglycemia 
    - Mild hypoglycemia referred to blood      
      glucose level less than 3.9 mmol/L 
    - Moderate hypoglycemia referred to  
      blood glucose level less than  
      3.1mmol/L 
    - Severe hypoglycemia referred to 
      blood glucose level less than 
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Table 1: Demographic and clinical characteristics of patients (N=207) 
 





Male 101 (48.8) 
Female 106 (51.2) 
Age  
Non-elderly 119 (57.5) 
Elderly 88 (42.5) 
Ethnicity  
Malay 80 (38.6) 
Chinese 45 (21.7) 
Indian 81 (39.1) 
Others 1 (0.5) 
Duration of diabetes  
≤ 10 years 38 (18.4) 
11-20 years 17 (8.2) 
21-30 years 12 (5.8) 
≥ 31 years 2 (1.0) 
Unknown 138 (66.7) 
BMI  
Underweight (<18.5) 5 (2.4) 
Normal range (18.5-24.9) 11 (5.3) 
Pre-obese (25-29.9) 9 (4.3) 
Obese (≥ 30) 6 (2.9) 
Unknown 176 (85.0) 
Smoking  
Yes 18 (8.7) 
No 105 (50.7) 
Ex-smoker 23 (11.1) 
Unknown 61 (29.5) 
Alcohol  
Yes 13 (6.3) 
No 114 (55.1) 
Ex-drinker 6 (2.9) 
Unknown 74 (35.7) 
* Non-elderly– less than 65 years old; elderly– 65 years old or more; * BMI = Weight (kg) ÷{[Height x Height (m2)} 
 





On admission During hospital stay  
Total 
(%) 
N = 566 
Number of episodes 
(%) 
n=98 
Number of episodes 
(%) 
n=468 
Insulin 22 (3.9%) 382 (67.5%) 404 (71.4%) 
*OHAs 12 (2.1%) 17 (3%) 29 (5.1%) 
Insulin + #LOA 4 (0.7%) 0 (0%) 4 (0.7%) 
*OHAs +#LOA 31 (5.5%) 1 (0.2%) 32 (5.7%) 
#LOA 5 (0.9%) 1 (0.2%) 6 (1.1%) 
Unknown 24 (4.2%) 67 (11.8%) 91 (16%) 
*OHAs – Oral Hypoglycemic Agents; #LOA – Loss of Appetite 
 




Severity of hypoglycemia δ P-value 
Mild Moderate Severe 
Insulin 238 (58.9%) 128 (31.7%) 38 (9.4%) 0.0001b 
OHAs 17 (58.6%) 6 (20.7%) 6 (20.7%)  
Insulin + LOA 1 (25%) 1 (25%) 2 (50%)  
OHAs + LOA 10 (31.2%) 12 (37.5%) 10 (31.2%)  
LOA 1 (16.7%) 1 (16.7%) 4 (66.7%)  
Unknown 58 (63.7%) 24 (26.4%) 9 (9.9%)  
*Severity of hypoglycemia reported as number of episodes (percentage across row, %); δ degree of freedom = 
10; b Monte Carlo Exact Test 
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Table 4: Factors significantly associated with severity of hypoglycemia episodes 
 
Characteristic *Severity of hypoglycemia δP-value 











































* Severity of hypoglycemia reported as number of episodes (percentage across row, %); δ degree of freedom = 2; 
a Pearson Chi Square Test. Note: Only significant factors were included 
 
Table 5: Comparison of the regimens of opioid with severity of hypoglycaemia 
 
Opioid *Severity of hypoglycemia δP-value 
Mild Moderate Severe 
Tramadol 50mg 124 (66%) 49 (26.1%) 15 (8%) 0.055b 
Morphine 1mg 1 (100%) 0 (0%) 0 (0%) 
Morphine 2mg 2 (66.7%) 0 (0%) 1 (33.3%) 
Not on opioid 198 (52.9%) 123 (32.9%) 53 (14.2%) 
*Severity of hypoglycemia reported as number of episodes (percentage across row, %); δ degree of freedom = 6; 
b Monte Carlo Exact Test 
 
Factors significantly associated with severity 
of hypoglycemia  
 
Three factors, which were age, presence of 
stroke and concomitant use of opioid during the 
hospitalization were found to be significantly 
associated with the severity of hypoglycemia in 
T2DM patients (p < 0.05). Elderly group is more 
likely to have severe hypoglycemia compared to 
non-elderly group. Besides that, patient suffered 
from stroke had higher probability having severe 
hypoglycemia compared to patient without 
stroke. On the other hand, concomitant use of 
opioid during hospitalization is highly associated 
with mild hypoglycemia. Table 4 summarized the 
factors that significantly associated with severity 
of hypoglycemia episodes. 
 
Since significant association was found between 
opioid and severity of hypoglycemia, we next 
analyze the dosing regimen of opioid associated 
with hypoglycemia. However, there is no 
significant association was found between dosing 




Hypertension was the most common comorbidity 
among the patients in this study (80.2 %) and 
this has also been the case in general in which it 
has been reported that more than 80 % of 
Malaysian adults’ diabetic patients has 
hypertension [16]. It has also been shown that 
hypertension was one of the most common 
comorbidity among T2DM patients in United 
State (67 %) [17]. There are many underlying 
pathophysiological mechanism that has been 
proposed to explain how diabetes can cause 
hypertension such as the stimulatory effect of 
hyperinsulinemia on sympathetic tone and the 
excitatory effect of hyperglycemia on the rennin-
angiotensin aldosterone (RAAS) system [18]. An 
additional risk factor such as lipid abnormalities 
may further increase the risk of hypertension in 
diabetes patients [7]. In this study, around 13 % 
of patients had dyslipidemia. 
 
Besides that, renal impairment’s comorbidity 
contributed around 30 % of patients in this study. 
However, study by Rajbharan et al [19] showed 
that only 20 % of T2DM patients had 
complication of renal impairment. The contrary of 
results could be due to quite a substantial 
proportions (13 %) of the patients in this study 
had dyslipidemia. There are evidences that lipid 
abnormalities may increase the risk of renal 
impairment [20,21]. These studies reported lipid 
fractions may induce mediators such as 
cytokines, reactive oxygen species and 
chemokines or through hemodynamic changes 
way to cause injury to both glomerular and 
tubulointerstitial injury. However, another study 
by John et al [20] suggested the important role of 
triglyceride that specifically produces reactive 
oxygen species that leads to the damage of 
glomerulus [20]. Therefore, there is higher 
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percentage of renal impairment in this study 
population. 
 
This study also found that antihypertensive 
agents that inclusive beta-blockers (23 %), 
calcium channel blockers (40.7 %), loop diuretics 
(10.5 %) and ACE inhibitors (32.7 %) in T2DM 
patients with hypoglycemia episodes. The high 
prescribing rate of antihypertensive agents 
concurred with the fact that hypertension was the 
most common comorbidities encounter in this 
study. This finding was supported by a local 
population study that showed a high percentage 
(75 %) of diabetes patients that received 
antihypertensive agents concurrently [16]. 
 
Besides that, the use of statins was also 
commonly seen in T2DM patients within this 
study. This is in line with the Malaysian Clinical 
Practice Guideline (CPG) on Management of 
T2DM in which all diabetic patients without overt 
cardiovascular disease (CVD) over the age of 40 
years and all patients with overt CVD should be 
treated with a statin regardless of baseline low 
density lipoprotein (LDL) cholesterol level [22]. 
Patients of age above 40 years old constitute 
around 95 % of population in this study.  
 
Antibiotics such as penicillin (61.3 %) and 
cephalosphorin (21 %) were among the most 
commonly prescribed medications in the cohort. 
This use of antibiotics was in agreement with the 
report from Centre for Healthcare Research & 
Transformation, University of Michigan (2011). 
Antibiotics were commonly used in diabetic 
patients because they are predisposed to the 
infections such as pneumonia, pyelonephritis and 
soft tissue infection including diabetic foot ulcer. 
The risk of getting infections is especially higher 
in the diabetic patients with cardiovascular 
disease comorbidities as shown in a study by 
Bertoni et al [23]. 
 
Of all episodes of hypoglycemia, mild 
hypoglycemia had the highest proportion (57.4 
%) followed by moderate (30.4 %) and the least 
was severe hypoglycemia (12.2 %). This trend 
was also observed by another study that include 
cohort in the same setting (UMMC) in which mild, 
moderate and severe hypoglycemia accounted 
for 46.3 %, 33.3 % and 20.4 % respectively [24]. 
Nevertheless, different definition was used to 
classify the severity of hypoglycemia as that 
study classified the patients based on symptoms 
while in our study patients were classified based 
on blood glucose readings. 
 
Age was found to be significantly associated with 
severe hypoglycemia (p = 0.011). This has also 
been reported by other authors [8,25]. Elderly 
patients are prone to severe hypoglycemia 
because the aging process modifies the counter-
regulatory response to become less effective in 
preventing hypoglycemia. Besides that, elderly 
patients have attenuated hypoglycemia response 
and the symptoms are usually present at severe 
stage of hypoglycemia [26]. Diminished 
autonomic symptoms such as fatigue and 
headache leads to late diagnosis of 
hypoglycemia and therefore elderly patients 
usually present to the hospitals with severe 
hypoglycemia [25]. 
 
Presence of stroke was found to be significantly 
(p = 0.033) associated with severe 
hypoglycemia. This observation could be due to 
poor glycemic control in stroke patients as 
researches have found that high blood glucose is 
associated with higher risk of macrovascular 
complications including stroke [27]. Poor 
glycemic controls are usually treated with 
aggressive insulin and OHAs therapy that in turn 
predispose patient to higher risk of hypoglycemia 
[8,9]. This explains why there is high incidence of 
severe hypoglycemia were observed in patient 
with stroke. 
 
Additionally, the association of stroke with severe 
hypoglycemia could be cofounded with patients’ 
age because the majority of patients which 
present with stroke are elderly (76.7 %) and as 
discussed earlier, advanced age was a 
significant predictor of more severe 
hypoglycemia in this study and other previously 




The use of opioid was found to be significantly 
associated with mild hypoglycemia (p = 0.008). 
Up to date, there are no clinical studies that have 
demonstrated this finding but there are 4 case 
reports of tramadol-induced hypoglycemia, which 
has been published in PubMed [28,29]. However, 
the underlying mechanisms of opioid induced 
hypoglycemia are unclear [29].An animal study in 
mice has also demonstrated the glucose 
lowering effect of methadone which is also an 




Approximately half of the episodes seen in this 
study are mild hypoglycemia followed by 
moderate and severe hypoglycemia. Factors 
identified to associate with severe hypoglycemia 
include elderly age and presence of stroke while 
concurrent use of opioid was associated with 
mild hypoglycemia. The identification of 
underlying factors associated with severity of 
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hypoglycemia may help in preventing and 
resolving hypoglycemia in T2DM patients. 
Hence, more attention is required for patients 
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